Numerous studies have also shown that BIRC5 overexpression is associated with angiogenesis and inhibition of cell apoptosis in lung cancer, thus making it a potential anti-NSCLC therapeutic biomarker [21,22,23,24]. The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.